Latest Daxor Corporation Stories
NEW YORK, Nov.
Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, announced the publication of a comparison study of the blood volume and anemia characteristics in heart failure patients in the October 2008 issue of The American Journal of Cardiology.
Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced a purchase by Union Hospital and a separate trial agreement for the Blood Volume Analyzer BVA-100. The purchase of the BVA-100 was received from Union Hospital of Elkton, Maryland.
Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced the June, 2008 publication of a clinical study in the Journal of Anesthesia and Analgesia titled, "Peripheral Blood Hematocrit in Critically Ill Surgical Patients: An Imprecise Surrogate of True Red Blood Cell Volume." The article reviews how transfusion errors may be avoided by including a blood volume measurement in critically ill surgical patients.
- A poem in which the author retracts something said in an earlier poem.